Medicare confirms payment for prostate cancer drug – San Francisco Chronicle



Medicare confirms payment for prostate cancer drug
San Francisco Chronicle
Medicare officials confirmed Thursday that the program will cover the $ 93000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the
Medicare to cover Dendreon's prostate drugReuters
Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $ 93000 Prostate Xconomy
Medicare confirms payment for prostate cancer drugNorthwest Cable News
Sacramento Bee
all 151 news articles »

DRUG – Google News


Short URL: http://trends-medical.com/?p=289

Posted by on Jun 30 2011. Filed under DRUGS & SUPPLEMENTS. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.

Comments are closed

Log in | Medical Trends & News Magazine